Area of research
Pollution · Oncology
Research interest
Research focused on Lung cancer and Cancer research, with related work in Gene knockdown, Breast cancer, Oncology. Notable publications include 'First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302): a multicentre, randomised, double-blind,...', 'Mitochondrial Dynamics Mediated by DRP1 and MFN2 Contributes to Cisplatin Chemoresistance in Human Ovarian Cancer SKOV3 cells', and 'Activation of p53 by costunolide blocks glutaminolysis and inhibits proliferation in human colorectal cancer cells'.
Safety of osimertinib in Chinese patients with non-small cell lung cancer: a multi-center, prospective, observational study
First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302): a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trial
Predictive value of inflammation and nutritional index in immunotherapy for stage IV non-small cell lung cancer and model construction
Expert consensus on the multidisciplinary diagnosis and treatment of multiple ground glass nodule-like lung cancer (2024 Edition) ∆
Efficacy, Safety, and Population Pharmacokinetics of MW032 Compared With Denosumab for Solid Tumor–Related Bone Metastases
New insights into nanosystems for non-small-cell lung cancer: diagnosis and treatment
MicroRNA-146a-5p induces cell cycle arrest and enhances apoptosis in gastric cancer via targeting CDC14A
Mitochondrial Dynamics Mediated by DRP1 and MFN2 Contributes to Cisplatin Chemoresistance in Human Ovarian Cancer SKOV3 cells
Penpulimab in combination with anlotinib as first-line treatment in advanced nonsquamous non-small-cell lung cancer.
LncRNA NEAT1 accelerates breast cancer progression through regulating miR-410-3p/ CCND1 axis
Diagnosis and Treatment of Rheumatic Adverse Events Related to Immune Checkpoint Inhibitors
IDO inhibitor synergized with radiotherapy to delay tumor growth by reversing T cell exhaustion
Activation of p53 by costunolide blocks glutaminolysis and inhibits proliferation in human colorectal cancer cells
Vascular endothelial growth factor gene polymorphism (-634G/C) and breast cancer risk
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Pollution · Oncology →